Home » Topics » Regulatory » Patents

Patents
RSS

Sentinel Oncology patents p70S6K inhibitors

Nov. 9, 2016

Guangdong Zhongsheng Pharmaceutical describes thromboxane synthase inhibitors

Nov. 8, 2016

Guangzhou Maxinovel Pharmaceuticals develops ALK tyrosine kinase receptor inhibitors

Nov. 8, 2016

H. Lundbeck patents PDE1 inhibitors

Nov. 8, 2016

University of British Columbia develops ERalpha antagonists

Nov. 7, 2016

Genentech and Roche describe NMDA receptor modulators

Nov. 7, 2016

Jiangsu Hengrui Medicine discloses IDO1 and/or TDO inhibitors

Nov. 7, 2016

Ruijin Hospital, Brandeis University and Xiamen University patent protein kinase inhibitors

Nov. 7, 2016

Merck KGaA presents novel activin receptor-like kinase inhibitors

Nov. 4, 2016

FORMA Therapeutics discovers new histone deacetylase inhibitors

Nov. 4, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...